Huntington National Bank Emergent Bio Solutions Inc. Transaction History

Huntington National Bank

  • $12.7 Billion
  • Q2 2024

A detailed history of Huntington National Bank transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Huntington National Bank holds 41 shares of EBS stock, worth $307. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41
Previous 41 -0.0%
Holding current value
$307
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
BUY
$1.5 - $3.41 $60 - $136
40 Added 4000.0%
41 $0
Q3 2023

Nov 08, 2023
SELL
$3.17 - $7.91 $98 - $245
-31 Reduced 96.88%
1 $0
Q2 2023

Aug 11, 2023
BUY
$7.35 - $13.21 $227 - $409
31 Added 3100.0%
32 $0
Q4 2021

Jan 21, 2022
SELL
$33.11 - $55.01 $33,772 - $56,110
-1,020 Reduced 99.9%
1 $0
Q3 2021

Oct 28, 2021
SELL
$50.07 - $66.05 $4,306 - $5,680
-86 Reduced 7.77%
1,021 $51,000
Q2 2021

Jul 30, 2021
SELL
$56.61 - $80.46 $12,454 - $17,701
-220 Reduced 16.58%
1,107 $70,000
Q1 2021

Apr 12, 2021
BUY
$86.23 - $125.19 $2,586 - $3,755
30 Added 2.31%
1,327 $123,000
Q4 2020

Jan 11, 2021
BUY
$79.17 - $111.47 $4,750 - $6,688
60 Added 4.85%
1,297 $116,000
Q3 2020

Oct 30, 2020
SELL
$81.91 - $134.94 $5,733 - $9,445
-70 Reduced 5.36%
1,237 $128,000
Q2 2020

Jul 30, 2020
BUY
$54.33 - $89.52 $13,202 - $21,753
243 Added 22.84%
1,307 $103,000
Q1 2020

Apr 27, 2020
SELL
$49.34 - $68.76 $10,805 - $15,058
-219 Reduced 17.07%
1,064 $62,000
Q4 2019

Jan 17, 2020
SELL
$51.21 - $59.06 $8,296 - $9,567
-162 Reduced 11.21%
1,283 $69,000
Q3 2019

Nov 01, 2019
SELL
$40.6 - $57.2 $64,919 - $91,462
-1,599 Reduced 52.53%
1,445 $76,000
Q2 2019

Jul 23, 2019
BUY
$39.92 - $53.86 $4,471 - $6,032
112 Added 3.82%
3,044 $147,000
Q1 2019

Apr 09, 2019
BUY
$48.23 - $66.16 $14,420 - $19,781
299 Added 11.36%
2,932 $148,000
Q4 2018

Jan 28, 2019
BUY
$55.63 - $73.24 $20,805 - $27,391
374 Added 16.56%
2,633 $156,000
Q3 2018

Oct 18, 2018
SELL
$52.05 - $66.51 $7,182 - $9,178
-138 Reduced 5.76%
2,259 $149,000
Q2 2018

Jul 19, 2018
SELL
$48.33 - $55.64 $1,304 - $1,502
-27 Reduced 1.11%
2,397 $121,000
Q1 2018

Apr 30, 2018
BUY
$44.44 - $54.39 $38,796 - $47,482
873 Added 56.29%
2,424 $128,000
Q4 2017

Feb 02, 2018
BUY
$37.77 - $47.75 $58,581 - $74,060
1,551
1,551 $72,000

Others Institutions Holding EBS

# of Institutions
154
Shares Held
30.2M
Call Options Held
137K
Put Options Held
706K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $373M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email